Inspire Investing, LLC Adaptimmune Therapeutics PLC Transaction History

Inspire Investing, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$1.33 - $2.28 $42,464 - $72,795	-31,928 Closed	0 $0
Q1 2022 Apr 21, 2022	BUY	$1.73 - $4.06 $20,280 - $47,595	11,723 Added 58.02%	31,928 $66,000
Q4 2021 Feb 14, 2022	BUY	$3.5 - $5.68 $16,842 - $27,332	4,812 Added 31.26%	20,205 $76,000
Q4 2021 Feb 03, 2022	BUY	$3.5 - $5.68 $53,875 - $87,432	15,393 New	15,393 $58,000

152M

78.5K

36.5K

Ticker ADAP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 163,370,000
Market Cap $160M
Description
Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...

Get notified when there are updates to the investment portfolio of Inspire Investing, LLC, based on Form 13F filings with the SEC.

Stay updated on Inspire Investing, LLC with notifications on news.